Depending on the particular autoimmune disease and stage of development, type I IFNs can promote disease through chemokine expression and antigen presentation or protect against damage through regulation of proinflammatory cytokines, including IL-1β and TNF-α (56). This evidence concerns the gene IL1B and autoimmune disease.